A novel vaccine adjuvant for recombinant flu antigens

A Novel M2e Based Flu Vaccine Formulation for Dogs

BACKGROUND The USA 2004 influenza virus outbreak H3N8 in dogs heralded the emergence of a new disease in this species. A new inactivated H3N8 vaccine was developed to control the spread of the disease but, as in humans and swine, it is anticipated that the virus will mutate shift and drift in the dog population. Therefore, there is a need for a vaccine that can trigger a broad protection to pre...

A Novel Recombinant Multisubunit Vaccine

The quest for a H1N1 flu vaccine.

Bacterial flagellin- a novel adjuvant for vaccine strategies

of papers 33 3. Abstract of papers Paper I. Immune response of Atlantic salmon to recombinant flagellin Many viral vaccines used in aquaculture are unable to stimulate an appropriate level of immunity to withstand infection. By targeting specific components of the immune system it may be possible to trigger stronger, more effective responses to antigens. Flagellin has the ability to stimulate b...

Strategy for approving a universal flu vaccine